Polish clinical trials market poised to grow by 5% in 2010 - April 2010

In 2010, the clinical trials market in Poland is expected to grow by 5% year on year, and to reach PLN 718m (€170m), according to our latest report, entitled “Clinical trials in Poland 2010. Development forecasts for 2010-2012”. If barriers to market growth, including unclear legislation and difficult trial registration procedures at the Central Register of Clinical Trials (the CEBK), were removed, the clinical trials market could develop even more rapidly.

To open the FULL free article/document, please sign up.

*required

*Email:
To make sure you receive the requested information, add info@pmrcorporate.com to your company trusted emails. Contact your IT department for details.
*Your company core business:
Help us better answer your needs.
Why do you sign up?
Please specify:

Privacy Policy

Free e-letters

  • Central Europe Pharma Headlines Central Europe Pharma Headlines bi-weekly e-letter on the pharma &healthcare in CEE
  • Pharma Poland Headlines Pharma Poland Headlines weekly e-letter on pharma & healthcare in Poland
unsubscribe »